meta_pixel
Tapesearch Logo
Log in
The Peter Attia Drive

#140 - Gerald Shulman, M.D., Ph.D.: A masterclass on insulin resistance—molecular mechanisms and clinical implications

The Peter Attia Drive

Peter Attia, MD

Health & Fitness, Medicine, Fitness

4.77.3K Ratings

🗓️ 7 December 2020

⏱️ 129 minutes

🧾️ Download transcript

Summary

Gerald Shulman is a Professor of Medicine, Cellular & Molecular Physiology, and the Director of the Diabetes Research Center at Yale. His pioneering work on the use of advanced technologies to analyze metabolic flux within cells has greatly contributed to the understanding of insulin resistance and type 2 diabetes. In this episode, Gerald clarifies what insulin resistance means as it relates to the muscle and the liver, and the evolutionary reason for its existence. He goes into depth on mechanisms that lead to and resolve insulin resistance, like the role of diet, exercise, and pharmacological agents. As a bonus, Gerald concludes with insights into Metformin’s mechanism of action and its suitability as a longevity agent.

We discuss:

  • Gerald’s background and interest in metabolism and insulin resistance (4:30);
  • Insulin resistance as a root cause of chronic disease (8:30);
  • How Gerald uses NMR to see inside cells (12:00);
  • Defining and diagnosing insulin resistance and type 2 diabetes (19:15);
  • The role of lipids in insulin resistance (31:15);
  • Confirmation of glucose transport as the root problem in lipid-induced insulin resistance (40:15);
  • The role of exercise in protecting against insulin resistance and fatty liver (50:00);
  • Insulin resistance in the liver (1:07:00);
  • The evolutionary explanation for insulin resistance—an important tool for surviving starvation (1:17:15);
  • The critical role of gluconeogenesis, and how it’s regulated by insulin (1:22:30);
  • Inflammation and body fat as contributing factors to insulin resistance (1:32:15);
  • Treatment approaches for fatty liver and insulin resistance, and an exciting new pharmacological approach (1:41:15);
  • Metformin’s mechanism of action and its suitability as a longevity agent (1:58:15);
  • More.

Learn more: https://peterattiamd.com/

Show notes page for this episode: https://peterattiamd.com/geraldshulman

Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/

Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on Facebook | Twitter | Instagram.

Transcript

Click on a timestamp to play from that location

0:00.0

Hey everyone, welcome to the Drive Podcast.

0:13.0

I'm your host, Peter Atia.

0:14.8

This podcast, my website, and my weekly newsletter, all focus on the goal of translating

0:18.7

the science of longevity into something accessible for everyone.

0:22.4

Our goal is to provide the best content in health and wellness, full stop, and we've assembled

0:27.0

a great team of analysts to make this happen.

0:29.4

If you enjoy this podcast, we've created a membership program that brings you far more

0:33.2

in depth content if you want to take your knowledge of this space to the next level.

0:37.3

At the end of this episode, I'll explain what those benefits are, or if you want to learn

0:41.0

more now, head over to peteratiamd.com forward slash subscribe.

0:46.3

Now without further delay, here's today's episode.

0:49.0

I guess this week is Dr. Gerald Schulman.

0:53.3

Cherry's a professor of medicine in cellular and molecular physiology at Yale.

0:57.1

He's also the co-director of the Yale Diabetes Research Center.

1:01.0

In 2018, he received the Banting Medal for Scientific Achievement, arguably the most prestigious

1:07.3

award one can win in this field.

1:09.4

He's pioneered the use of magnetic resonance spectroscopy combined with mass spec to non-invasively

1:15.4

examine cellular glucose and fat metabolism.

1:17.9

Now you may ask, why does that matter?

1:20.3

And we get to that right at the outset of this interview.

1:23.4

If you want to understand insulin resistance, if you want to understand hyperinsulinemia,

1:28.8

type 2 diabetes, non-alcoholic fatty liver disease, you have to understand the movement

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Peter Attia, MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Peter Attia, MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.